Thyroid cancer is rapidly increasing in incidence, but the mortality rate remains flat. Debate
has arisen over the need to detect or treat most thyroid cancers early, given their favorable …

are new to this edition. The authors provide not only the The second edition of Thyroid
Cancer: A Comp-most current review of their respective areas, but also their hensive Guide …

Objective: The incidence of thyroid cancer, the most common endocrine malignancy, has
increased dramatically in the last fifty years. This article will review the standard approach to …

Differentiated thyroid cancer, which includes papillary and follicular histologies, is a common
malignancy and is increasing in incidence. It carries a favorable prognosis compared to …

Thyroid cancer is uncommon with an estimated lifetime risk of 0.8% for women and 0.3% for
men. The incidence appears to be increasing by 4% per year and is currently the eighth …

The incidence of thyroid cancer has risen in recent years. In the United States, the incidence
increased at an annual rate of 5.4% in men and 6.5% in women from 2006 to 2010. 1 …

Thyroid cancer is increasing all over the world. The exact cause of this increase is still
debated and there are conflicting reports. Sophisticated molecular studies suggest that …

The lack of prospective randomized clinical trials for most management topics in
differentiated thyroid cancer forces us to make management recommendations based on …

Recently, there have been important advances in the diagnosis of thyroid cancer as well as
in our understanding of the biologic nature of thyroid cancer. Most patients with thyroid …

Controversy continues regarding the optimal management of patients with differentiated
thyroid cancer because no prospective randomized studies evaluating the merits of (1) …